G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $106,128 | 0.0% | 39,600 | 0.0% | 0.00% | – |
Q1 2023 | $106,128 | +58.9% | 39,600 | +222.0% | 0.00% | – |
Q4 2022 | $66,789 | -100.0% | 12,300 | -70.0% | 0.00% | – |
Q1 2022 | $311,684,000 | -25.6% | 41,011 | 0.0% | 0.00% | – |
Q4 2021 | $418,722,000 | -23.9% | 41,011 | 0.0% | 0.00% | – |
Q3 2021 | $550,368,000 | -38.8% | 41,011 | 0.0% | 0.00% | – |
Q2 2021 | $899,781,000 | -1.9% | 41,011 | +7.6% | 0.00% | – |
Q1 2021 | $916,975,000 | +50.4% | 38,112 | +12.5% | 0.00% | – |
Q4 2020 | $609,681,000 | +109.1% | 33,890 | +34.3% | 0.00% | – |
Q3 2020 | $291,557,000 | -49.6% | 25,243 | +5.8% | 0.00% | – |
Q2 2020 | $578,965,000 | -75.1% | 23,865 | -88.7% | 0.00% | -100.0% |
Q1 2020 | $2,326,465,000 | -65.1% | 211,113 | -16.3% | 0.00% | -50.0% |
Q4 2019 | $6,666,598,000 | +19.7% | 252,236 | +3.2% | 0.00% | 0.0% |
Q3 2019 | $5,567,341,000 | -27.2% | 244,396 | -2.0% | 0.00% | -20.0% |
Q2 2019 | $7,642,986,000 | +238.6% | 249,282 | +83.3% | 0.01% | +150.0% |
Q1 2019 | $2,257,401,000 | -12.9% | 135,988 | +0.5% | 0.00% | 0.0% |
Q4 2018 | $2,590,554,000 | -67.0% | 135,277 | -9.8% | 0.00% | -66.7% |
Q3 2018 | $7,839,108,000 | – | 149,916 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |